drugset / Trial / NCT01347294
Compare Two Different Sclerosing Agents in the Treatment of Venous Malformations
RandomizedFactorialTriple-blindTreatment
Summary
The purpose of this study is to determine the effectiveness of bleomycin, fibrovein and bleomycin and fibrovein in the treatment of venous malformation.
Timeline
- Start
- 2011-08
- Primary completion
- 2023-11-30
- Completion
- 2025-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Bleomycin | Unknown | 1000 iu | Intramuscular |
| Subject | Tetradecyl Sodium Sulphate | Unknown | 3 % | Intramuscular |